DTL
AKRO

Dynamic Technology Lab’s Akero Therapeutics AKRO Stock Holding History

Dynamic Technology Lab’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,748
Closed -$246K – 913
2024
Q1 		$246K Buy
+9,748
New +$234K 0.03% 853
2023
Q4 		– Sell
-8,060
Closed -$408K – 1003
2023
Q3 		$408K Buy
+8,060
New +$375K 0.04% 559
2022
Q3 		– Sell
-28,155
Closed -$266K – 1094
2022
Q2 		$266K Buy
+28,155
New +$294K 0.03% 811

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dynamic Technology Lab's AKRO Position: Q2 2024 in Review

Dynamic Technology Lab sold out of Akero Therapeutics (AKRO) in Q2 2024, closing a stake of 9,748 shares — an estimated $246K sold.

Dynamic Technology Lab first reported a position in AKRO in Q2 2022 and held it in 3 quarters. The position peaked at $408K in Q3 2023. 153 funds tracked by Wall St. Rank hold AKRO as of Q2 2024.

  • Dynamic Technology Lab reported no remaining Akero Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 9,748 Akero Therapeutics shares in Q2 2024, an estimated $246K.
  • Dynamic Technology Lab first reported a position in Akero Therapeutics in Q2 2022 and held it in 3 quarters.
  • Dynamic Technology Lab's Akero Therapeutics position peaked at $408K in Q3 2023.
  • 153 funds tracked by Wall St. Rank held Akero Therapeutics as of Q2 2024.

Based on Dynamic Technology Lab's 13F filing for Q2 2024, filed 15 Aug 2024.